Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside
Anandita Agarwala,1 Renato Quispe,2 Anne C Goldberg,3 Erin D Michos2 1Division of Cardiology, Baylor Scott and White Health, Heart Hospital Baylor Plano, Plano, TX, USA; 2Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Department of Medicine, Johns Hopkins Univ...
Main Authors: | Agarwala A, Quispe R, Goldberg AC, Michos ED |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-05-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/bempedoic-acid-for-heterozygous-familial-hypercholesterolemia-from-ben-peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Bempedoic acid for the treatment of dyslipidemia
by: Joel C Marrs, et al.
Published: (2020-08-01) -
Familial hypercholesterolemia: current status of the problem, treatment, and prevention
by: S. A. Bliznyuk, et al.
Published: (2020-11-01) -
Homozygous familial hypercholesterolemia
by: Ravi Kumar Parihar, et al.
Published: (2012-01-01) -
Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials
by: Xiang Zhao, et al.
Published: (2020-12-01) -
Modern strategy of diagnosis and treatment of children with heterozygous familial hypercholesterolemia
by: I. V. Leontyeva
Published: (2020-09-01)